Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Jared Bunch

Showing results (201-210 of 330) with videos related to

Pageof 33
Sort By:
The American Journal of Cardiology|March 23, 2005
Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failureT Jared Bunch, Joseph B Muhlestein, Tami L Bair, et al.
Critical Pathways in Cardiology|February 22, 2023
Protocol Development and Initial Experience With Intravenous Sotalol Loading for Atrial ArrhythmiasMelissa L Feuerborn, John Dechand, Rohith S Vadlamudi, et al.
JACC. Clinical Electrophysiology|August 23, 2024
Discordant Treatment Goals for Patients With Atrial Fibrillation and Clinical Trials MetricsBrian Zenger, John A Spertus, Michael Torre, et al.
Critical Pathways in Cardiology|November 22, 2022
Ejection Fraction Improvement Does Not Reflect Changes in Quality of Life Following Cardiac Resynchronization TherapyScott A Rizzi, Michael Torre, T Jared Bunch, et al.
The American Journal of Cardiology|March 11, 2008
Frequency of helicobacter pylori seropositivity and C-reactive protein increase in atrial fibrillation in patients undergoing coronary angiographyT Jared Bunch, John D Day, Jeffrey L Anderson, et al.
Pacing and Clinical Electrophysiology : PACE|May 9, 2009
Atrial fibrillation and CHADS2 risk factors are associated with highly sensitive C-reactive protein incrementally and independentlyMark A Crandall, Benjamin D Horne, John D Day, et al.
Heart Rhythm O2|May 1, 2023
Major drivers of healthcare system costs and cost variability for routine atrial fibrillation ablationBrian Zenger, Haojia Li, T Jared Bunch, et al.
Journal of Cardiovascular Electrophysiology|November 14, 2017
Five-year impact of catheter ablation for atrial fibrillation in patients with a prior history of strokeT Jared Bunch, Heidi T May, Tami L Bair, et al.
Heart Rhythm O2|November 4, 2024
Performance of off-the-shelf machine learning architectures and biases in low left ventricular ejection fraction detectionJake A Bergquist, Brian Zenger, James Brundage, et al.
Journal of Cardiovascular Electrophysiology|March 3, 2023
Response to "Delay in AF ablation costs lives"Andrew J Sessions, Heidi T May, Brian G Crandall, et al.
Pageof 33

Showing results (201-210 of 330) with videos related to

Sort By:
Pageof 33
The American Journal of Cardiology|March 23, 2005
Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failureT Jared Bunch, Joseph B Muhlestein, Tami L Bair, et al.
Critical Pathways in Cardiology|February 22, 2023
Protocol Development and Initial Experience With Intravenous Sotalol Loading for Atrial ArrhythmiasMelissa L Feuerborn, John Dechand, Rohith S Vadlamudi, et al.
JACC. Clinical Electrophysiology|August 23, 2024
Discordant Treatment Goals for Patients With Atrial Fibrillation and Clinical Trials MetricsBrian Zenger, John A Spertus, Michael Torre, et al.
Critical Pathways in Cardiology|November 22, 2022
Ejection Fraction Improvement Does Not Reflect Changes in Quality of Life Following Cardiac Resynchronization TherapyScott A Rizzi, Michael Torre, T Jared Bunch, et al.
The American Journal of Cardiology|March 11, 2008
Frequency of helicobacter pylori seropositivity and C-reactive protein increase in atrial fibrillation in patients undergoing coronary angiographyT Jared Bunch, John D Day, Jeffrey L Anderson, et al.
Pacing and Clinical Electrophysiology : PACE|May 9, 2009
Atrial fibrillation and CHADS2 risk factors are associated with highly sensitive C-reactive protein incrementally and independentlyMark A Crandall, Benjamin D Horne, John D Day, et al.
Heart Rhythm O2|May 1, 2023
Major drivers of healthcare system costs and cost variability for routine atrial fibrillation ablationBrian Zenger, Haojia Li, T Jared Bunch, et al.
Journal of Cardiovascular Electrophysiology|November 14, 2017
Five-year impact of catheter ablation for atrial fibrillation in patients with a prior history of strokeT Jared Bunch, Heidi T May, Tami L Bair, et al.
Heart Rhythm O2|November 4, 2024
Performance of off-the-shelf machine learning architectures and biases in low left ventricular ejection fraction detectionJake A Bergquist, Brian Zenger, James Brundage, et al.
Journal of Cardiovascular Electrophysiology|March 3, 2023
Response to "Delay in AF ablation costs lives"Andrew J Sessions, Heidi T May, Brian G Crandall, et al.
Pageof 33